![Michael Mullette](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Mullette
Corporate Officer/Principal at
VAXCYTE, INC.
Profile
Mr. Michael Mullette is a Chief Commercial Officer at Vaxcyte, Inc. Mr. Mullette was previously employed as a Chief Executive & Operating Officer by Lykos Therapeutics, Inc. and a Managing Director-Canada by Moderna, Inc. He received his undergraduate degree from Villanova University and an MBA from Lehigh University.
Michael Mullette active positions
| Companies | Position | Start |
|---|---|---|
| VAXCYTE, INC. | Corporate Officer/Principal | - |
Former positions of Michael Mullette
| Companies | Position | End |
|---|---|---|
Lykos Therapeutics PBC
 Lykos Therapeutics PBC BiotechnologyHealth Technology Engages in healing and well-being through psychedelic drug development & therapist training programs | Chief Executive Officer | 01/11/2025 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Training of Michael Mullette
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Engages in healing and well-being through psychedelic drug development & therapist training programs | Health Technology |
- Stock Market
- Insiders
- Michael Mullette
